Global and China Glucagon Like Peptide 2 Receptor Market Insights, Forecast to 2027

Global and China Glucagon Like Peptide 2 Receptor Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Glucagon Like Peptide 2 Receptor Product Introduction
1.2 Market by Type
1.2.1 Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Type
1.2.2 FE-203799
1.2.3 Glepaglutide
1.2.4 GXG-8
1.2.5 HM-15910
1.2.6 Others
1.3 Market by Application
1.3.1 Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Application
1.3.2 Short Bowel Syndrome
1.3.3 Diabetes
1.3.4 Diarrhea
1.3.5 Obesity
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Glucagon Like Peptide 2 Receptor Market Size, Estimates and Forecasts
2.1.1 Global Glucagon Like Peptide 2 Receptor Revenue 2016-2027
2.1.2 Global Glucagon Like Peptide 2 Receptor Sales 2016-2027
2.2 Global Glucagon Like Peptide 2 Receptor, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Glucagon Like Peptide 2 Receptor Historical Market Size by Region (2016-2021)
2.3.1 Global Glucagon Like Peptide 2 Receptor Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Glucagon Like Peptide 2 Receptor Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Glucagon Like Peptide 2 Receptor Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Region (2022-2027)
2.4.2 Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Region (2022-2027)
3 Global Glucagon Like Peptide 2 Receptor Competitor Landscape by Players
3.1 Global Top Glucagon Like Peptide 2 Receptor Manufacturers by Sales
3.1.1 Global Glucagon Like Peptide 2 Receptor Sales by Manufacturer (2016-2021)
3.1.2 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Glucagon Like Peptide 2 Receptor Manufacturers by Revenue
3.2.1 Key Glucagon Like Peptide 2 Receptor Manufacturers Covered: Ranking by Revenue
3.2.2 Global Glucagon Like Peptide 2 Receptor Revenue by Manufacturers (2016-2021)
3.2.3 Global Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Glucagon Like Peptide 2 Receptor Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Glucagon Like Peptide 2 Receptor Revenue in 2020
3.2.6 Global Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Glucagon Like Peptide 2 Receptor Price by Manufacturers
3.4 Global Glucagon Like Peptide 2 Receptor Manufacturing Base Distribution, Product Types
3.4.1 Glucagon Like Peptide 2 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glucagon Like Peptide 2 Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Glucagon Like Peptide 2 Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Glucagon Like Peptide 2 Receptor Market Size by Type (2016-2021)
4.1.1 Global Glucagon Like Peptide 2 Receptor Sales by Type (2016-2021)
4.1.2 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2016-2021)
4.1.3 Glucagon Like Peptide 2 Receptor Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Glucagon Like Peptide 2 Receptor Market Size Forecast by Type (2022-2027)
4.2.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Type (2022-2027)
4.2.2 Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Type (2022-2027)
4.2.3 Glucagon Like Peptide 2 Receptor Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Glucagon Like Peptide 2 Receptor Market Size by Application (2016-2021)
5.1.1 Global Glucagon Like Peptide 2 Receptor Sales by Application (2016-2021)
5.1.2 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2016-2021)
5.1.3 Glucagon Like Peptide 2 Receptor Price by Application (2016-2021)
5.2 Glucagon Like Peptide 2 Receptor Market Size Forecast by Application (2022-2027)
5.2.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Application (2022-2027)
5.2.2 Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Application (2022-2027)
5.2.3 Global Glucagon Like Peptide 2 Receptor Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Glucagon Like Peptide 2 Receptor Market Size YoY Growth 2016-2027
6.1.1 China Glucagon Like Peptide 2 Receptor Sales YoY Growth 2016-2027
6.1.2 China Glucagon Like Peptide 2 Receptor Revenue YoY Growth 2016-2027
6.1.3 China Glucagon Like Peptide 2 Receptor Market Share in Global Market 2016-2027
6.2 China Glucagon Like Peptide 2 Receptor Market Size by Players (International and Local Players)
6.2.1 China Top Glucagon Like Peptide 2 Receptor Players by Sales (2016-2021)
6.2.2 China Top Glucagon Like Peptide 2 Receptor Players by Revenue (2016-2021)
6.3 China Glucagon Like Peptide 2 Receptor Historic Market Review by Type (2016-2021)
6.3.1 China Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2016-2021)
6.3.2 China Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2016-2021)
6.3.3 China Glucagon Like Peptide 2 Receptor Price by Type (2016-2021)
6.4 China Glucagon Like Peptide 2 Receptor Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Glucagon Like Peptide 2 Receptor Sales Forecast by Type (2022-2027)
6.4.2 China Glucagon Like Peptide 2 Receptor Revenue Forecast by Type (2022-2027)
6.4.3 China Glucagon Like Peptide 2 Receptor Price Forecast by Type (2022-2027)
6.5 China Glucagon Like Peptide 2 Receptor Historic Market Review by Application (2016-2021)
6.5.1 China Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2016-2021)
6.5.2 China Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2016-2021)
6.5.3 China Glucagon Like Peptide 2 Receptor Price by Application (2016-2021)
6.6 China Glucagon Like Peptide 2 Receptor Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Glucagon Like Peptide 2 Receptor Sales Forecast by Application (2022-2027)
6.6.2 China Glucagon Like Peptide 2 Receptor Revenue Forecast by Application (2022-2027)
6.6.3 China Glucagon Like Peptide 2 Receptor Price Forecast by Application (2022-2027)
7 North America
7.1 North America Glucagon Like Peptide 2 Receptor Market Size YoY Growth 2016-2027
7.2 North America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country
7.2.1 North America Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021)
7.2.2 North America Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Glucagon Like Peptide 2 Receptor Market Size YoY Growth 2016-2027
8.2 Asia Pacific Glucagon Like Peptide 2 Receptor Market Facts & Figures by Region
8.2.1 Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2016-2021)
8.2.2 Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Glucagon Like Peptide 2 Receptor Market Size YoY Growth 2016-2027
9.2 Europe Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country
9.2.1 Europe Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021)
9.2.2 Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Glucagon Like Peptide 2 Receptor Market Size YoY Growth 2016-2027
10.2 Latin America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country
10.2.1 Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021)
10.2.2 Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country
11.2.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021)
11.2.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Hanmi Pharmaceuticals Co Ltd
12.1.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
12.1.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview
12.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
12.1.5 Hanmi Pharmaceuticals Co Ltd Recent Development
12.2 Naia Ltd
12.2.1 Naia Ltd Corporation Information
12.2.2 Naia Ltd Description and Business Overview
12.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Naia Ltd Glucagon Like Peptide 2 Receptor Products Offered
12.2.5 Naia Ltd Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Description and Business Overview
12.3.3 Takeda Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Glucagon Like Peptide 2 Receptor Products Offered
12.3.5 Takeda Recent Development
12.4 Tasly Pharmaceutical Group Co Ltd
12.4.1 Tasly Pharmaceutical Group Co Ltd Corporation Information
12.4.2 Tasly Pharmaceutical Group Co Ltd Description and Business Overview
12.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
12.4.5 Tasly Pharmaceutical Group Co Ltd Recent Development
12.5 Zealand Pharma AS
12.5.1 Zealand Pharma AS Corporation Information
12.5.2 Zealand Pharma AS Description and Business Overview
12.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Products Offered
12.5.5 Zealand Pharma AS Recent Development
12.11 Hanmi Pharmaceuticals Co Ltd
12.11.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
12.11.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview
12.11.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
12.11.5 Hanmi Pharmaceuticals Co Ltd Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Glucagon Like Peptide 2 Receptor Industry Trends
13.2 Glucagon Like Peptide 2 Receptor Market Drivers
13.3 Glucagon Like Peptide 2 Receptor Market Challenges
13.4 Glucagon Like Peptide 2 Receptor Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glucagon Like Peptide 2 Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of FE-203799
Table 3. Major Manufacturers of Glepaglutide
Table 4. Major Manufacturers of GXG-8
Table 5. Major Manufacturers of HM-15910
Table 6. Major Manufacturers of Others
Table 7. Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 8. Global Glucagon Like Peptide 2 Receptor Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Glucagon Like Peptide 2 Receptor Sales by Regions (2016-2021) & (K Pcs)
Table 10. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Regions (2016-2021)
Table 11. Global Glucagon Like Peptide 2 Receptor Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Region (2022-2027) & (K Pcs)
Table 13. Global Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Glucagon Like Peptide 2 Receptor Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Glucagon Like Peptide 2 Receptor Sales by Manufacturers (2016-2021) (K Pcs)
Table 17. Global Glucagon Like Peptide 2 Receptor Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Glucagon Like Peptide 2 Receptor Manufacturers by Revenue (US$ Million) in 2020
Table 19. Glucagon Like Peptide 2 Receptor Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2016-2021)
Table 21. Global Glucagon Like Peptide 2 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Glucagon Like Peptide 2 Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Like Peptide 2 Receptor as of 2020)
Table 23. Key Manufacturers Glucagon Like Peptide 2 Receptor Price (2016-2021) (USD/Pcs)
Table 24. Glucagon Like Peptide 2 Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Glucagon Like Peptide 2 Receptor Product Type
Table 26. Date of International Manufacturers Enter into Glucagon Like Peptide 2 Receptor Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Glucagon Like Peptide 2 Receptor Sales by Type (2016-2021) (K Pcs)
Table 29. Global Glucagon Like Peptide 2 Receptor Sales Share by Type (2016-2021)
Table 30. Global Glucagon Like Peptide 2 Receptor Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Glucagon Like Peptide 2 Receptor Revenue Share by Type (2016-2021)
Table 32. Glucagon Like Peptide 2 Receptor Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 33. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Type (2022-2027) & (K Pcs)
Table 34. Global Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Glucagon Like Peptide 2 Receptor Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Glucagon Like Peptide 2 Receptor Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Glucagon Like Peptide 2 Receptor Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 38. Global Glucagon Like Peptide 2 Receptor Sales by Application (2016-2021) (K Pcs)
Table 39. Global Glucagon Like Peptide 2 Receptor Sales Share by Application (2016-2021)
Table 40. Global Glucagon Like Peptide 2 Receptor Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Glucagon Like Peptide 2 Receptor Revenue Share by Application (2016-2021)
Table 42. Glucagon Like Peptide 2 Receptor Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 43. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Application (2022-2027) & (K Pcs)
Table 44. Global Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Glucagon Like Peptide 2 Receptor Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Glucagon Like Peptide 2 Receptor Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 48. China Glucagon Like Peptide 2 Receptor Sales (K Pcs) of Key Companies (2016-2021)
Table 49. China Glucagon Like Peptide 2 Receptor Sales Share by Company (2016-2021)
Table 50. China Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Company (2016-2021)
Table 51. China Glucagon Like Peptide 2 Receptor Revenue Share by Company (2016-2021)
Table 52. China Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2016-2021)
Table 53. China Glucagon Like Peptide 2 Receptor Sales Share by Type (2016-2021)
Table 54. China Glucagon Like Peptide 2 Receptor Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Type (2016-2021)
Table 56. China Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2022-2027)
Table 57. China Glucagon Like Peptide 2 Receptor Sales Share by Type (2022-2027)
Table 58. China Glucagon Like Peptide 2 Receptor Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China Glucagon Like Peptide 2 Receptor Revenue Share by Type (2022-2027)
Table 60. China Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Type (2022-2027)
Table 61. China Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Application (2016-2021)
Table 62. China Glucagon Like Peptide 2 Receptor Sales Share by Application (2016-2021)
Table 63. China Glucagon Like Peptide 2 Receptor Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Application (2016-2021)
Table 65. China Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Application (2022-2027)
Table 66. China Glucagon Like Peptide 2 Receptor Sales Share by Application (2022-2027)
Table 67. China Glucagon Like Peptide 2 Receptor Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China Glucagon Like Peptide 2 Receptor Revenue Share by Application (2022-2027)
Table 69. China Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Application (2022-2027)
Table 70. North America Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021) & (K Pcs)
Table 71. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2016-2021)
Table 72. North America Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2016-2021) & (K Pcs)
Table 75. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2016-2021)
Table 78. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021) & (K Pcs)
Table 79. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2016-2021)
Table 80. Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2016-2021)
Table 82. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021) & (K Pcs)
Table 83. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021) & (K Pcs)
Table 87. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2016-2021)
Table 90. Hanmi Pharmaceuticals Co Ltd Corporation Information
Table 91. Hanmi Pharmaceuticals Co Ltd Description and Business Overview
Table 92. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 93. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product
Table 94. Hanmi Pharmaceuticals Co Ltd Recent Development
Table 95. Naia Ltd Corporation Information
Table 96. Naia Ltd Description and Business Overview
Table 97. Naia Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 98. Naia Ltd Product
Table 99. Naia Ltd Recent Development
Table 100. Takeda Corporation Information
Table 101. Takeda Description and Business Overview
Table 102. Takeda Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 103. Takeda Product
Table 104. Takeda Recent Development
Table 105. Tasly Pharmaceutical Group Co Ltd Corporation Information
Table 106. Tasly Pharmaceutical Group Co Ltd Description and Business Overview
Table 107. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 108. Tasly Pharmaceutical Group Co Ltd Product
Table 109. Tasly Pharmaceutical Group Co Ltd Recent Development
Table 110. Zealand Pharma AS Corporation Information
Table 111. Zealand Pharma AS Description and Business Overview
Table 112. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Zealand Pharma AS Product
Table 114. Zealand Pharma AS Recent Development
Table 115. Glucagon Like Peptide 2 Receptor Market Trends
Table 116. Glucagon Like Peptide 2 Receptor Market Drivers
Table 117. Glucagon Like Peptide 2 Receptor Market Challenges
Table 118. Glucagon Like Peptide 2 Receptor Market Restraints
Table 119. Glucagon Like Peptide 2 Receptor Customers List
Table 120. Glucagon Like Peptide 2 Receptor Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Like Peptide 2 Receptor Product Picture
Figure 2. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type in 2020 & 2027
Figure 3. FE-203799 Product Picture
Figure 4. Glepaglutide Product Picture
Figure 5. GXG-8 Product Picture
Figure 6. HM-15910 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application in 2020 & 2027
Figure 9. Short Bowel Syndrome
Figure 10. Diabetes
Figure 11. Diarrhea
Figure 12. Obesity
Figure 13. Others
Figure 14. Glucagon Like Peptide 2 Receptor Report Years Considered
Figure 15. Global Glucagon Like Peptide 2 Receptor Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Glucagon Like Peptide 2 Receptor Market Size 2016-2027 (US$ Million)
Figure 17. Global Glucagon Like Peptide 2 Receptor Sales 2016-2027 (K Pcs)
Figure 18. Global Glucagon Like Peptide 2 Receptor Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2016-2021)
Figure 20. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region in 2020
Figure 21. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2016-2021)
Figure 22. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region in 2020
Figure 23. Global Glucagon Like Peptide 2 Receptor Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Glucagon Like Peptide 2 Receptor Revenue in 2020
Figure 25. Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2016-2021)
Figure 27. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type in 2020
Figure 28. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2016-2021)
Figure 29. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type in 2020
Figure 30. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2016-2021)
Figure 31. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application in 2020
Figure 32. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2016-2021)
Figure 33. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application in 2020
Figure 34. China Glucagon Like Peptide 2 Receptor Sales Growth Rate 2016-2027 (K Pcs)
Figure 35. China Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. China Glucagon Like Peptide 2 Receptor Market Share in Global Market 2016-2027
Figure 37. China 5 and 10 Largest Glucagon Like Peptide 2 Receptor Players Market Share by Revenue in Glucagon Like Peptide 2 Receptor in 2020
Figure 38. China Glucagon Like Peptide 2 Receptor Revenue Share by Type (2016-2021)
Figure 39. China Glucagon Like Peptide 2 Receptor Revenue Growth Rate by Type in 2016 & 2020
Figure 40. China Glucagon Like Peptide 2 Receptor Revenue Share by Application (2016-2021)
Figure 41. China Glucagon Like Peptide 2 Receptor Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Glucagon Like Peptide 2 Receptor Sales Growth Rate 2016-2021 (K Pcs)
Figure 43. North America Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Country in 2020
Figure 45. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country in 2020
Figure 46. U.S. Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 47. U.S. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 49. Canada Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Glucagon Like Peptide 2 Receptor Sales Growth Rate 2016-2021 (K Pcs)
Figure 51. Europe Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Country in 2020
Figure 53. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Country in 2020
Figure 54. Germany Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 55. Germany Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 57. France Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 59. U.K. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 61. Italy Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 63. Russia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Growth Rate 2016-2021 (K Pcs)
Figure 65. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Region in 2020
Figure 67. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Market Share by Region in 2020
Figure 68. China Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 69. China Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 71. Japan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 73. South Korea Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 75. India Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 77. Australia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Taiwan Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 79. Taiwan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 81. Indonesia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 83. Thailand Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 85. Malaysia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Philippines Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 87. Philippines Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Vietnam Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 89. Vietnam Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Latin America Glucagon Like Peptide 2 Receptor Sales Growth Rate 2016-2021 (K Pcs)
Figure 91. Latin America Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2016-2021 (US$ Million)
Figure 92. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Country in 2020
Figure 93. Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country in 2020
Figure 94. Mexico Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
Figure 95. Mexico Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Brazil Glucagon Like Peptide 2 Receptor Sales Growth Rate (2016-2021) (K Pcs)
F

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs